• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BIT 8.00% 2.7¢

BIOTRON LIMITED - News & Media

Biotron Limited is an Australia-based biotechnology company. The Company is primarily... Biotron Limited is an Australia-based biotechnology company. The Company is primarily engaged in the funding and management of intermediate and applied biotechnology research and development projects. The Company’s clinical programs include BIT225-001, BIT225-003, BIT225-004, BIT225-005, BIT225-006, BIT225-007 and BIT225-008. BIT225 is in mid-stage clinical development for treatment of HIV-1 and Hepatitis C virus (HCV) infections, with seven clinical trials completed. BIT225 is a HIV-1 Vpu protein inhibitor with the aim of inhibiting virus replication in cellular reservoirs. BIT225 is a viral assembly inhibitor that targets HCV p7 protein. In addition to the development of BIT225, the Company has a portfolio of preclinical antiviral programs developing drugs targeting a range of significant established and emerging viral diseases such as Dengue, Zika and Influenza virus.More

(20min delay)
Last
2.7¢
Change
0.002(8.00%)
Mkt cap ! $24.36M
Open High Low Value Volume
2.6¢ 2.8¢ 2.5¢ $23.28K 893.7K

Buyers (Bids)

No. Vol. Price($)
1 15384 2.6¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 396594 2
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
Last
2.8¢
  Change
0.002 ( 12.0 %)
Open High Low Volume
2.5¢ 2.8¢ 2.5¢ 326107
Last updated 15.56pm 23/08/2024 ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.